Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Malagelada, C; Keller, J; Sifrim, D; Serra, J; Tack, J; Mulak, A; Stengel, A; Aguilar, A; Drewes, AM; Josefsson, A; Bonaz, B; Dumitrascu, D; Keszthelyi, D; Barba, E; Carbone, F; Zerbib, F; Marchegiani, G; Hauser, G; Gourcerol, G; Tornblom, H; Hammer, H; Aziz, I; Matic, JR; Mendive, J; Nikaki, K; Wauters, L; Alcalá-González, L; Waluga, M; Jinga, M; Corsetti, M; Rommel, N; Shidrawi, R; De, Giorgio, R; Kadirkamanathan, S; Surdea-Blaga, T.
European Guideline on Chronic Nausea and Vomiting-A UEG and ESNM Consensus for Clinical Management.
United European Gastroenterol J. 2025; Doi: 10.1002/ueg2.12711 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Co-authors Med Uni Graz: Hammer Heinz
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: INTRODUCTION: Chronic nausea and vomiting are symptoms of a wide range of gastrointestinal and non-gastrointestinal conditions. Diagnosis can be challenging and requires a systematic and well-structured approach. If the initial investigation for structural, toxic and metabolic disorders is negative, digestive motility and gut-brain interaction disorders should be assessed. United European Gastroenterology (UEG) and the European Society for Neurogastroenterology and Motility (ESNM) identified the need for an updated, evidence-based clinical guideline for the management of chronic nausea and vomiting. METHODS: A multidisciplinary team of experts in the field, including European specialists and national societies, participated in the development of the guideline. Relevant questions were addressed through a literature review and statements were developed and voted on according to a Delphi process. RESULTS: Ninety-eight statements were identified and voted following the Delphi process. Overall agreement was high, although the grade of scientific evidence was low in many areas. Disagreement was more evident for some pharmacological treatment options. A diagnostic algorithm was developed, focussing on the differentiating features between gastrointestinal motility and gut-brain interaction disorders with predominant nausea and vomiting. CONCLUSION: These guidelines provide an evidence-based framework for the evaluation and treatment of patients with chronic nausea and vomiting.
Find related publications in this database (Keywords): Delphi; guidelines; nausea; vomiting